Jasper Therapeutics, Inc. (JSPR) Operating income 2020–2025
Jasper Therapeutics, Inc. (JSPR) annual operating income history from SEC filings — each fiscal year as reported.
-$83.9MFY2025 · since FY2020: -$20.7M → -$83.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$83.9M | -10.0% |
| FY2024 | -$76.2M | -10.7% |
| FY2023 | -$68.9M | -34.5% |
| FY2022 | -$51.2M | -39.0% |
| FY2021 | -$36.8M | -78.1% |
| FY2020 | -$20.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JSPR financial trends
JSPR RevenueJSPR Net incomeJSPR Net marginJSPR Gross profitJSPR Gross marginJSPR Operating marginJSPR Operating cash flowJSPR Free cash flowJSPR Capital expendituresJSPR Return on equityJSPR Stock buybacksJSPR Dividends paidJSPR Total assetsJSPR Total liabilitiesJSPR Shareholders’ equityJSPR overview →